[Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].
Identifieur interne : 000563 ( Main/Merge ); précédent : 000562; suivant : 000564[Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].
Auteurs : M. Frikha [Tunisie] ; N. Toumi ; L. Ghorbel ; H. Ben Salah ; A. Khabir ; H. Karray ; R. Gargouri ; T. Boudawara ; A. Ghorbel ; J. DaoudSource :
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [ 1769-6658 ] ; 2010.
Descripteurs français
- KwdFr :
- Adolescent, Association thérapeutique, Bléomycine (administration et posologie), Carcinomes (radiothérapie), Carcinomes (traitement médicamenteux), Carcinomes (épidémiologie), Cisplatine (administration et posologie), Enfant, Estimation de Kaplan-Meier, Femelle, Fluorouracil (administration et posologie), Humains, Jeune adulte, Mâle, Métastase lymphatique, Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Radio-isotopes du cobalt (usage thérapeutique), Radiothérapie conformationnelle, Récidive tumorale locale (radiothérapie), Récidive tumorale locale (traitement médicamenteux), Résultat thérapeutique, Seconde tumeur primitive (), Seconde tumeur primitive (étiologie), Survie sans rechute, Traitement médicamenteux adjuvant, Traitement néoadjuvant, Tumeurs du rhinopharynx (radiothérapie), Tumeurs du rhinopharynx (traitement médicamenteux), Tumeurs du rhinopharynx (épidémiologie), Tumeurs radio-induites (étiologie), Télégammathérapie (effets indésirables), Xérostomie (épidémiologie), Xérostomie (étiologie), Épirubicine (administration et posologie), Études de suivi, Études rétrospectives.
- MESH :
- administration et posologie : Bléomycine, Cisplatine, Fluorouracil, Épirubicine.
- effets indésirables : Télégammathérapie.
- radiothérapie : Carcinomes, Récidive tumorale locale, Tumeurs du rhinopharynx.
- traitement médicamenteux : Carcinomes, Récidive tumorale locale, Tumeurs du rhinopharynx.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique, Radio-isotopes du cobalt.
- épidémiologie : Carcinomes, Tumeurs du rhinopharynx, Xérostomie.
- étiologie : Seconde tumeur primitive, Tumeurs radio-induites, Xérostomie.
- Adolescent, Association thérapeutique, Enfant, Estimation de Kaplan-Meier, Femelle, Humains, Jeune adulte, Mâle, Métastase lymphatique, Radiothérapie conformationnelle, Résultat thérapeutique, Seconde tumeur primitive, Survie sans rechute, Traitement médicamenteux adjuvant, Traitement néoadjuvant, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adolescent, Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Bleomycin (administration & dosage), Carcinoma (drug therapy), Carcinoma (epidemiology), Carcinoma (radiotherapy), Chemotherapy, Adjuvant, Child, Cisplatin (administration & dosage), Cobalt Radioisotopes (therapeutic use), Combined Modality Therapy, Disease-Free Survival, Epirubicin (administration & dosage), Female, Fluorouracil (administration & dosage), Follow-Up Studies, Humans, Kaplan-Meier Estimate, Lymphatic Metastasis, Male, Nasopharyngeal Neoplasms (drug therapy), Nasopharyngeal Neoplasms (epidemiology), Nasopharyngeal Neoplasms (radiotherapy), Neoadjuvant Therapy, Neoplasm Recurrence, Local (drug therapy), Neoplasm Recurrence, Local (radiotherapy), Neoplasms, Radiation-Induced (etiology), Neoplasms, Second Primary (chemically induced), Neoplasms, Second Primary (etiology), Radioisotope Teletherapy (adverse effects), Radiotherapy, Conformal, Retrospective Studies, Treatment Outcome, Xerostomia (epidemiology), Xerostomia (etiology), Young Adult.
- MESH :
- chemical , administration & dosage : Bleomycin, Cisplatin, Epirubicin, Fluorouracil.
- adverse effects : Radioisotope Teletherapy.
- chemically induced : Neoplasms, Second Primary.
- drug therapy : Carcinoma, Nasopharyngeal Neoplasms, Neoplasm Recurrence, Local.
- epidemiology : Carcinoma, Nasopharyngeal Neoplasms, Xerostomia.
- etiology : Neoplasms, Radiation-Induced, Neoplasms, Second Primary, Xerostomia.
- radiotherapy : Carcinoma, Nasopharyngeal Neoplasms, Neoplasm Recurrence, Local.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols, Cobalt Radioisotopes.
- Adolescent, Chemotherapy, Adjuvant, Child, Combined Modality Therapy, Disease-Free Survival, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Lymphatic Metastasis, Male, Neoadjuvant Therapy, Radiotherapy, Conformal, Retrospective Studies, Treatment Outcome, Young Adult.
Abstract
We retrospectively analyzed anatomoclinic, therapeutic and evolutive particularities of 74 young patients (< or =20 years) with nasopharyngeal carcinoma treated between 1993 and 2005.
DOI: 10.1016/j.canrad.2010.01.003
PubMed: 20347607
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000053
- to stream PubMed, to step Curation: 000053
- to stream PubMed, to step Checkpoint: 000053
- to stream Ncbi, to step Merge: 000128
- to stream Ncbi, to step Curation: 000128
- to stream Ncbi, to step Checkpoint: 000128
Links to Exploration step
pubmed:20347607Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].</title>
<author><name sortKey="Frikha, M" sort="Frikha, M" uniqKey="Frikha M" first="M" last="Frikha">M. Frikha</name>
<affiliation wicri:level="1"><nlm:affiliation>CHU Habib-Bourguiba, Sfax, Tunisie.</nlm:affiliation>
<country xml:lang="fr">Tunisie</country>
<wicri:regionArea>CHU Habib-Bourguiba, Sfax</wicri:regionArea>
<wicri:noRegion>Sfax</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Toumi, N" sort="Toumi, N" uniqKey="Toumi N" first="N" last="Toumi">N. Toumi</name>
</author>
<author><name sortKey="Ghorbel, L" sort="Ghorbel, L" uniqKey="Ghorbel L" first="L" last="Ghorbel">L. Ghorbel</name>
</author>
<author><name sortKey="Ben Salah, H" sort="Ben Salah, H" uniqKey="Ben Salah H" first="H" last="Ben Salah">H. Ben Salah</name>
</author>
<author><name sortKey="Khabir, A" sort="Khabir, A" uniqKey="Khabir A" first="A" last="Khabir">A. Khabir</name>
</author>
<author><name sortKey="Karray, H" sort="Karray, H" uniqKey="Karray H" first="H" last="Karray">H. Karray</name>
</author>
<author><name sortKey="Gargouri, R" sort="Gargouri, R" uniqKey="Gargouri R" first="R" last="Gargouri">R. Gargouri</name>
</author>
<author><name sortKey="Boudawara, T" sort="Boudawara, T" uniqKey="Boudawara T" first="T" last="Boudawara">T. Boudawara</name>
</author>
<author><name sortKey="Ghorbel, A" sort="Ghorbel, A" uniqKey="Ghorbel A" first="A" last="Ghorbel">A. Ghorbel</name>
</author>
<author><name sortKey="Daoud, J" sort="Daoud, J" uniqKey="Daoud J" first="J" last="Daoud">J. Daoud</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20347607</idno>
<idno type="pmid">20347607</idno>
<idno type="doi">10.1016/j.canrad.2010.01.003</idno>
<idno type="wicri:Area/PubMed/Corpus">000053</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000053</idno>
<idno type="wicri:Area/PubMed/Curation">000053</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000053</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000053</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000053</idno>
<idno type="wicri:Area/Ncbi/Merge">000128</idno>
<idno type="wicri:Area/Ncbi/Curation">000128</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000128</idno>
<idno type="wicri:Area/Main/Merge">000563</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].</title>
<author><name sortKey="Frikha, M" sort="Frikha, M" uniqKey="Frikha M" first="M" last="Frikha">M. Frikha</name>
<affiliation wicri:level="1"><nlm:affiliation>CHU Habib-Bourguiba, Sfax, Tunisie.</nlm:affiliation>
<country xml:lang="fr">Tunisie</country>
<wicri:regionArea>CHU Habib-Bourguiba, Sfax</wicri:regionArea>
<wicri:noRegion>Sfax</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Toumi, N" sort="Toumi, N" uniqKey="Toumi N" first="N" last="Toumi">N. Toumi</name>
</author>
<author><name sortKey="Ghorbel, L" sort="Ghorbel, L" uniqKey="Ghorbel L" first="L" last="Ghorbel">L. Ghorbel</name>
</author>
<author><name sortKey="Ben Salah, H" sort="Ben Salah, H" uniqKey="Ben Salah H" first="H" last="Ben Salah">H. Ben Salah</name>
</author>
<author><name sortKey="Khabir, A" sort="Khabir, A" uniqKey="Khabir A" first="A" last="Khabir">A. Khabir</name>
</author>
<author><name sortKey="Karray, H" sort="Karray, H" uniqKey="Karray H" first="H" last="Karray">H. Karray</name>
</author>
<author><name sortKey="Gargouri, R" sort="Gargouri, R" uniqKey="Gargouri R" first="R" last="Gargouri">R. Gargouri</name>
</author>
<author><name sortKey="Boudawara, T" sort="Boudawara, T" uniqKey="Boudawara T" first="T" last="Boudawara">T. Boudawara</name>
</author>
<author><name sortKey="Ghorbel, A" sort="Ghorbel, A" uniqKey="Ghorbel A" first="A" last="Ghorbel">A. Ghorbel</name>
</author>
<author><name sortKey="Daoud, J" sort="Daoud, J" uniqKey="Daoud J" first="J" last="Daoud">J. Daoud</name>
</author>
</analytic>
<series><title level="j">Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</title>
<idno type="eISSN">1769-6658</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Bleomycin (administration & dosage)</term>
<term>Carcinoma (drug therapy)</term>
<term>Carcinoma (epidemiology)</term>
<term>Carcinoma (radiotherapy)</term>
<term>Chemotherapy, Adjuvant</term>
<term>Child</term>
<term>Cisplatin (administration & dosage)</term>
<term>Cobalt Radioisotopes (therapeutic use)</term>
<term>Combined Modality Therapy</term>
<term>Disease-Free Survival</term>
<term>Epirubicin (administration & dosage)</term>
<term>Female</term>
<term>Fluorouracil (administration & dosage)</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Kaplan-Meier Estimate</term>
<term>Lymphatic Metastasis</term>
<term>Male</term>
<term>Nasopharyngeal Neoplasms (drug therapy)</term>
<term>Nasopharyngeal Neoplasms (epidemiology)</term>
<term>Nasopharyngeal Neoplasms (radiotherapy)</term>
<term>Neoadjuvant Therapy</term>
<term>Neoplasm Recurrence, Local (drug therapy)</term>
<term>Neoplasm Recurrence, Local (radiotherapy)</term>
<term>Neoplasms, Radiation-Induced (etiology)</term>
<term>Neoplasms, Second Primary (chemically induced)</term>
<term>Neoplasms, Second Primary (etiology)</term>
<term>Radioisotope Teletherapy (adverse effects)</term>
<term>Radiotherapy, Conformal</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
<term>Xerostomia (epidemiology)</term>
<term>Xerostomia (etiology)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Association thérapeutique</term>
<term>Bléomycine (administration et posologie)</term>
<term>Carcinomes (radiothérapie)</term>
<term>Carcinomes (traitement médicamenteux)</term>
<term>Carcinomes (épidémiologie)</term>
<term>Cisplatine (administration et posologie)</term>
<term>Enfant</term>
<term>Estimation de Kaplan-Meier</term>
<term>Femelle</term>
<term>Fluorouracil (administration et posologie)</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Métastase lymphatique</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Radio-isotopes du cobalt (usage thérapeutique)</term>
<term>Radiothérapie conformationnelle</term>
<term>Récidive tumorale locale (radiothérapie)</term>
<term>Récidive tumorale locale (traitement médicamenteux)</term>
<term>Résultat thérapeutique</term>
<term>Seconde tumeur primitive ()</term>
<term>Seconde tumeur primitive (étiologie)</term>
<term>Survie sans rechute</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Traitement néoadjuvant</term>
<term>Tumeurs du rhinopharynx (radiothérapie)</term>
<term>Tumeurs du rhinopharynx (traitement médicamenteux)</term>
<term>Tumeurs du rhinopharynx (épidémiologie)</term>
<term>Tumeurs radio-induites (étiologie)</term>
<term>Télégammathérapie (effets indésirables)</term>
<term>Xérostomie (épidémiologie)</term>
<term>Xérostomie (étiologie)</term>
<term>Épirubicine (administration et posologie)</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Bleomycin</term>
<term>Cisplatin</term>
<term>Epirubicin</term>
<term>Fluorouracil</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Bléomycine</term>
<term>Cisplatine</term>
<term>Fluorouracil</term>
<term>Épirubicine</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Radioisotope Teletherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Neoplasms, Second Primary</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Carcinoma</term>
<term>Nasopharyngeal Neoplasms</term>
<term>Neoplasm Recurrence, Local</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Télégammathérapie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Carcinoma</term>
<term>Nasopharyngeal Neoplasms</term>
<term>Xerostomia</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Neoplasms, Radiation-Induced</term>
<term>Neoplasms, Second Primary</term>
<term>Xerostomia</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Carcinoma</term>
<term>Nasopharyngeal Neoplasms</term>
<term>Neoplasm Recurrence, Local</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Carcinomes</term>
<term>Récidive tumorale locale</term>
<term>Tumeurs du rhinopharynx</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
<term>Cobalt Radioisotopes</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Carcinomes</term>
<term>Récidive tumorale locale</term>
<term>Tumeurs du rhinopharynx</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term>
<term>Radio-isotopes du cobalt</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Carcinomes</term>
<term>Tumeurs du rhinopharynx</term>
<term>Xérostomie</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Seconde tumeur primitive</term>
<term>Tumeurs radio-induites</term>
<term>Xérostomie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Chemotherapy, Adjuvant</term>
<term>Child</term>
<term>Combined Modality Therapy</term>
<term>Disease-Free Survival</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Kaplan-Meier Estimate</term>
<term>Lymphatic Metastasis</term>
<term>Male</term>
<term>Neoadjuvant Therapy</term>
<term>Radiotherapy, Conformal</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Association thérapeutique</term>
<term>Enfant</term>
<term>Estimation de Kaplan-Meier</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Métastase lymphatique</term>
<term>Radiothérapie conformationnelle</term>
<term>Résultat thérapeutique</term>
<term>Seconde tumeur primitive</term>
<term>Survie sans rechute</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Traitement néoadjuvant</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We retrospectively analyzed anatomoclinic, therapeutic and evolutive particularities of 74 young patients (< or =20 years) with nasopharyngeal carcinoma treated between 1993 and 2005.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000563 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000563 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Terre |area= CobaltMaghrebV1 |flux= Main |étape= Merge |type= RBID |clé= pubmed:20347607 |texte= [Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:20347607" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a CobaltMaghrebV1
![]() | This area was generated with Dilib version V0.6.32. | ![]() |